<--- Back to Details
First PageDocument Content
Food and Drug Administration / Clinical research / Pharmaceutical industry / Clinical pharmacology / Artemether / Novartis / New Drug Application / Plasmodium falciparum / Center for Drug Evaluation and Research / Pharmaceutical sciences / Pharmacology / Medicine
Date: 2008-12-01 09:01:37
Food and Drug Administration
Clinical research
Pharmaceutical industry
Clinical pharmacology
Artemether
Novartis
New Drug Application
Plasmodium falciparum
Center for Drug Evaluation and Research
Pharmaceutical sciences
Pharmacology
Medicine

FOOD AND DRUG ADMINISTRATION

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 21,79 KB

Share Document on Facebook

Similar Documents

Diplomarbeit Andreas Bender, Johann Wolfgang Goethe-University Frankfurt Research Group Prof. Dr. Gisbert Schneider, April 2002 – September 2002 Abstract The malaria causing protozoan Plasmodium falciparum (P. falcipar

DocID: 1uVGe - View Document

Exercise – Plasmodium falciparum and SNPs Go to Ensembl Protists and search for glucose-6-phosphate 1-dehydrogenase. Filter the results for Plasmodium falciparum only. a) How is this gene named in Ensembl Protists?

DocID: 1un8t - View Document

Key Morphological Differences Between Human Plasmodium Species in Blood Smears The ring forms of all four species are very similar and difficult to distinguish. P. falciparum rings tend to be a little smaller and more nu

DocID: 1umfT - View Document

ENHANCED PROTECTIVE EFFICACY OF A PLASMODIUM FALCIPARUM MALARIA VACCINE USING A HETEROLOGOUS PRIME-BOOST IMMUNIZATION WITH A BACULOVIRAL

DocID: 1tPZr - View Document

Plasmodium falciparum erythrocyte membrane protein 1

DocID: 1tuQB - View Document